Daily as of 3 Nov 16:00 ET
- Price
- below both $3.74 vs 50 $4.78 / 200 $4.54
- Projection
- 💀Death cross projected in 7 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 2 Oct 2025 · projected 17 bars out · tested 6 bars
ACRS | Aclaris TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$3.74
-$0.06 (-1.58%)
Aclaris Therapeutics (ACRS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Oct 2025, but the two have been closing on each other and a death cross is projected within 10 bars. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $3.97 vs 50 $4.22 / 200 $4.04
- Projection
- No cross projected
- Test
- Active cross test, 1 bar at the 200, 5 bars left
- Last cross
- 🟨Golden cross week of 12 Oct 2026 · projected 25 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- below both $3.78 vs 50 $3.88 / 200 $5.13
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 7 Oct 2026 · projected 23 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| week of 12 Oct 2026 | 🟨Golden moderate | weekly | 25 bars out | Active Cross Test |
| 7 Oct 2026 | 💀Death | 4-hour | 23 bars out | Not tested |
| 2 Oct 2025 | 🟨Golden moderate | daily | 17 bars out | 6 bar cross test |
| 15 Jul 2025 | 🟨Golden | 4-hour | 19 bars out | — |
| 9 Apr 2025 | 💀Death steep | daily | 26 bars out | Not tested |
About ACRS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$10.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall